Musaffa Logo
Guilin Sanjin Pharmaceutical Co Ltd 002275.SZ

Last Updated: Jul 21, 12:00 AM·SZSE

Guilin Sanjin Pharmaceutical Co Ltd

Guilin Sanjin Pharmaceutical Co Ltd. Stock Analysis 002275.SZ

China Health Care Small Cap
Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research and production of traditional Chinese and Natural medicine. The company is headquartered in Guilin, Guangxi and currently employs 2,556 full-time employees. The company went IPO on 2009-07-10. The firm mainly operates in the two major areas of oral and throat health and urinary health, including the prevention, self-treatment and rehabilitation of common household diseases such as cardiovascular and cerebrovascular, nervous system, respiratory system and digestive system. The firm's main products include Sanjin Tablets, Guilin Xiguashuang, Xiguashuang Throat Tablets, Xiguashuang Qingyan Lozenges, Naomaitai Capsules, Xuanyunning Tablets/Granules, Gejie Dingchuan Capsules, Yuye Jiedu Granules.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!